Trademark Overview
On Wednesday, May 13, 2026, a trademark application was filed for YOLEMBI with the United States Patent and Trademark Office. The USPTO has given the YOLEMBI trademark a serial number of 99821535. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Wednesday, May 13, 2026. This trademark is owned by Hong Kong King-Friend, Industrial Company, Ltd.. The YOLEMBI trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceuticals; pharmaceutical preparations; pharmaceutical products; biologics; biosimilars; follicle-stimulating hormone (FSH); follicle-stimulating hormone (FSH) biosimilars; follitropin biosimilars; pharmaceutical preparations for the treatment of infertility; pharmaceutical preparations for stimulation of human fertility; biosimilars for the treatment of infertility; biosimilars for stimulation of human fertility; pharmaceutical preparations, namely, injectable follicle-stimulating hormone (FSH); pharmaceutical preparations, namely, injectable follicle-stimulating hormone (FSH) biosimilars; pharmaceutical preparations, namely, injectable follitropin biosimilars; pharmaceutical preparations, namely, injectable biosimilars for stimulation of human fertility; injectors sold filled with follicle-stimulating hormone (FSH); injectors sold filled with follicle-stimulating hormone (FSH) biosimilars; injectors sold filled with follitropin biosimilars; injectors sold filled with pharmaceut...
